Inside Innovation

Aptevo Therapeutics, a Seattle-based clinical-stage biotechnology company, has received a $500,000 investment from Niowave, a Michigan-based medical radioisotopes company, as part of a collaboration to

Seattle-based AGC Biologics has been selected by Japanese pharmaceutical company Teikoku Seiyaku to provide microbial contract development and manufacturing services for KTP-001, a recombinant human

The Pacific Northwest is rapidly advancing as a center for AI-driven drug discovery through coordinated federal initiatives, startup investment, and expanding research infrastructure across Seattle,

Anthropic and the Gates Foundation have launched a four-year, $200 million partnership to support artificial intelligence initiatives focused on global health, education, and public-interest research.

Life sciences and health innovation companies were among the organizations recognized at the 2026 GeekWire Awards, highlighting the growing influence of Washington’s biotech, healthcare, and

A new editorial highlights Spokane’s rapid emergence as a major contributor to Washington’s expanding life sciences industry. The article points to recent investments including new

AGC Biologics received the 2026 Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance in recognition of its regulatory strategy, quality systems, and compliance

Fred Hutch Cancer Center researchers published a large-scale study showing that many FDA-approved kinase inhibitors can effectively target additional cancer-driving mutations beyond their original intended

Just-Evotec has launched its J.Train continuous biomanufacturing platform to the broader market following validation through a facility sale to Sandoz. The platform integrates end-to-end continuous

Achieve Life Sciences has appointed Andrew Goldberg as CEO while securing up to $354 million in funding to support its smoking cessation treatment and operations.

Washington’s life sciences employment grew 50% from 2014 to 2024, continuing to expand even as national job numbers declined slightly. The state added jobs year

Seattle scientist Fred Ramsdell’s decades-long research into regulatory T cells culminated in a Nobel Prize and continues to shape new cell therapies. Ramsdell’s work began